Proto Labs Competitors

Proto Labs (NYSE:PRLB) and Illinois Tool Works (NYSE:ITW) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership.

Valuation & Earnings

This table compares Proto Labs and Illinois Tool Works' revenue, earnings per share and valuation.

Illinois Tool Works has higher revenue and earnings than Proto Labs. Illinois Tool Works is trading at a lower price-to-earnings ratio than Proto Labs, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Proto Labs and Illinois Tool Works, as provided by MarketBeat.

Proto Labs presently has a consensus target price of $201.00, indicating a potential upside of 84.69%. Illinois Tool Works has a consensus target price of $210.1250, indicating a potential downside of 5.19%. Given Proto Labs' stronger consensus rating and higher possible upside, research analysts clearly believe Proto Labs is more favorable than Illinois Tool Works.

Institutional and Insider Ownership

77.4% of Illinois Tool Works shares are owned by institutional investors. 0.9% of Proto Labs shares are owned by company insiders. Comparatively, 0.8% of Illinois Tool Works shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Proto Labs and Illinois Tool Works' net margins, return on equity and return on assets.

Risk and Volatility

Proto Labs has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Comparatively, Illinois Tool Works has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500.

Summary

Illinois Tool Works beats Proto Labs on 8 of the 14 factors compared between the two stocks.

Parker-Hannifin (NYSE:PH) and Proto Labs (NYSE:PRLB) are both industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, risk and profitability.

Analyst Ratings

This is a summary of recent recommendations for Parker-Hannifin and Proto Labs, as provided by MarketBeat.

Parker-Hannifin presently has a consensus target price of $310.6429, suggesting a potential downside of 2.21%. Proto Labs has a consensus target price of $201.00, suggesting a potential upside of 84.69%. Given Proto Labs' higher probable upside, analysts plainly believe Proto Labs is more favorable than Parker-Hannifin.

Risk & Volatility

Parker-Hannifin has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Comparatively, Proto Labs has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

Earnings and Valuation

This table compares Parker-Hannifin and Proto Labs' gross revenue, earnings per share (EPS) and valuation.

Parker-Hannifin has higher revenue and earnings than Proto Labs. Parker-Hannifin is trading at a lower price-to-earnings ratio than Proto Labs, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

77.4% of Parker-Hannifin shares are held by institutional investors. 1.5% of Parker-Hannifin shares are held by insiders. Comparatively, 0.9% of Proto Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Parker-Hannifin and Proto Labs' net margins, return on equity and return on assets.

Summary

Parker-Hannifin beats Proto Labs on 8 of the 14 factors compared between the two stocks.

Proto Labs (NYSE:PRLB) and Stanley Black & Decker (NYSE:SWK) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Proto Labs and Stanley Black & Decker, as reported by MarketBeat.com.

Proto Labs presently has a consensus target price of $201.00, indicating a potential upside of 84.69%. Stanley Black & Decker has a consensus target price of $191.1538, indicating a potential downside of 5.10%. Given Proto Labs' higher possible upside, equities analysts clearly believe Proto Labs is more favorable than Stanley Black & Decker.

Valuation & Earnings

This table compares Proto Labs and Stanley Black & Decker's revenue, earnings per share and valuation.

Stanley Black & Decker has higher revenue and earnings than Proto Labs. Stanley Black & Decker is trading at a lower price-to-earnings ratio than Proto Labs, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

85.4% of Stanley Black & Decker shares are held by institutional investors. 0.9% of Proto Labs shares are held by insiders. Comparatively, 1.0% of Stanley Black & Decker shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Proto Labs has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Comparatively, Stanley Black & Decker has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500.

Profitability

This table compares Proto Labs and Stanley Black & Decker's net margins, return on equity and return on assets.

Summary

Stanley Black & Decker beats Proto Labs on 8 of the 14 factors compared between the two stocks.

Ingersoll Rand (NYSE:IR) and Proto Labs (NYSE:PRLB) are both industrial products companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations.

Volatility and Risk

Ingersoll Rand has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500. Comparatively, Proto Labs has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

Institutional and Insider Ownership

95.9% of Ingersoll Rand shares are owned by institutional investors. 0.7% of Ingersoll Rand shares are owned by insiders. Comparatively, 0.9% of Proto Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Ingersoll Rand and Proto Labs, as reported by MarketBeat.com.

Ingersoll Rand presently has a consensus target price of $50.0909, indicating a potential upside of 1.40%. Proto Labs has a consensus target price of $201.00, indicating a potential upside of 84.69%. Given Proto Labs' higher probable upside, analysts clearly believe Proto Labs is more favorable than Ingersoll Rand.

Profitability

This table compares Ingersoll Rand and Proto Labs' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Ingersoll Rand and Proto Labs' gross revenue, earnings per share and valuation.

Ingersoll Rand has higher revenue and earnings than Proto Labs. Proto Labs is trading at a lower price-to-earnings ratio than Ingersoll Rand, indicating that it is currently the more affordable of the two stocks.

Summary

Proto Labs beats Ingersoll Rand on 8 of the 14 factors compared between the two stocks.

Proto Labs (NYSE:PRLB) and Dover (NYSE:DOV) are both industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.

Valuation and Earnings

This table compares Proto Labs and Dover's revenue, earnings per share (EPS) and valuation.

Dover has higher revenue and earnings than Proto Labs. Dover is trading at a lower price-to-earnings ratio than Proto Labs, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Proto Labs and Dover, as provided by MarketBeat.

Proto Labs currently has a consensus target price of $201.00, indicating a potential upside of 84.69%. Dover has a consensus target price of $132.25, indicating a potential downside of 4.37%. Given Proto Labs' higher probable upside, research analysts clearly believe Proto Labs is more favorable than Dover.

Profitability

This table compares Proto Labs and Dover's net margins, return on equity and return on assets.

Institutional and Insider Ownership

82.7% of Dover shares are held by institutional investors. 0.9% of Proto Labs shares are held by company insiders. Comparatively, 1.0% of Dover shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Proto Labs has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Comparatively, Dover has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.

Summary

Dover beats Proto Labs on 9 of the 14 factors compared between the two stocks.

Xylem (NYSE:XYL) and Proto Labs (NYSE:PRLB) are both industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Earnings and Valuation

This table compares Xylem and Proto Labs' gross revenue, earnings per share (EPS) and valuation.

Xylem has higher revenue and earnings than Proto Labs. Xylem is trading at a lower price-to-earnings ratio than Proto Labs, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Xylem and Proto Labs' net margins, return on equity and return on assets.

Volatility & Risk

Xylem has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, Proto Labs has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Xylem and Proto Labs, as provided by MarketBeat.

Xylem currently has a consensus price target of $84.5455, indicating a potential downside of 21.57%. Proto Labs has a consensus price target of $201.00, indicating a potential upside of 84.69%. Given Proto Labs' stronger consensus rating and higher possible upside, analysts clearly believe Proto Labs is more favorable than Xylem.

Insider and Institutional Ownership

84.9% of Xylem shares are held by institutional investors. 1.0% of Xylem shares are held by company insiders. Comparatively, 0.9% of Proto Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Xylem beats Proto Labs on 8 of the 14 factors compared between the two stocks.